CD80 and neoplasm: By transfecting CLDN+ PA-1 and Colo-699-N tumor cells with costimulatory molecules CD80 and 4-1BBL (ref. 46; Supplementary Fig. S7A), we markedly improved antigen-dependent proliferation of CLDN-TCAR transfected or transduced T cells.